Product Description
Tafecta is the 1st global generic of Tenofovir Alafenamide. Tenofovir Alafenamide is an oral nucleoside reverse transcriptase inhibitor (NRTIs).It is indicated for the treatment of chronic hepatitis b virus (HBV) infection in adults with compensated liver disease.